Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach

出版年份 2015 全文链接

标题

作者

关键词

出版物

Volume 174, Issue 3, Pages 473-477

出版商

Wiley

发表日期

2015-10-13

DOI

10.1111/bjh.13776

参考文献

查看 1 条相关文献

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now